Tyers Asset Management’s Haemonetics HAE Stock Holding History

Tyers Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$727K	Buy	5,760 +192	+3%	+$24.4K	0.02%	387
2019 Q2	$670K	Hold	5,568	–	–	0.02%	407
2019 Q1	$487K	Buy	5,568 +192	+4%	+$17.5K	0.02%	476
2018 Q4	$538K	Hold	5,376	–	–	0.02%	397
2018 Q3	$616K	Buy	5,376 +1,184	+28%	+$123K	0.02%	423
2018 Q2	$376K	Hold	4,192	–	–	0.01%	511
2018 Q1	$307K	Hold	4,192	–	–	0.01%	552
2017 Q4	$243K	Buy	4,192 +720	+21%	+$37.9K	0.01%	632
2017 Q3	$156K	Buy	3,472 +352	+11%	+$14.6K	0.01%	713
2017 Q2	$123K	Buy	3,120 +1,440	+86%	+$59.1K	﹤0.01%	742
2017 Q1	$68K	Hold	1,680	–	–	﹤0.01%	766
2016 Q4	$67K	Buy	+1,680	New	+$63.3K	﹤0.01%	739

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tyers Asset Management's HAE Position: Q3 2019 in Review

Tyers Asset Management increased its Haemonetics (HAE) stake by 3.4% in Q3 2019, buying an estimated $24.4K and bringing the position to 5,760 shares worth $727K. The position accounts for 0.02% of the portfolio, ranked #387.

Tyers Asset Management first reported a position in HAE in Q4 2016 and has held it in 12 quarters since. 275 funds tracked by Wall St. Rank hold HAE as of Q3 2019.

Tyers Asset Management held 5,760 shares of Haemonetics worth $727K as of Q3 2019.
Tyers Asset Management bought 192 Haemonetics shares in Q3 2019, an estimated $24.4K.
Haemonetics made up 0.02% of Tyers Asset Management's portfolio in Q3 2019, its #387 holding.
Tyers Asset Management first reported a position in Haemonetics in Q4 2016 and has held it in 12 quarters since.
275 funds tracked by Wall St. Rank held Haemonetics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.